IRIS
LANZILLO, ROBERTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.141
NA - Nord America 11.931
EU - Europa 8.668
SA - Sud America 1.530
Continente sconosciuto - Info sul continente non disponibili 721
AF - Africa 305
OC - Oceania 21
Totale 35.317
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.340
SG - Singapore 5.194
RU - Federazione Russa 3.457
CN - Cina 2.318
VN - Vietnam 2.115
IT - Italia 2.016
BR - Brasile 1.201
HK - Hong Kong 993
NL - Olanda 754
DE - Germania 638
FR - Francia 471
CA - Canada 363
GB - Regno Unito 317
IN - India 284
FI - Finlandia 268
JP - Giappone 234
BD - Bangladesh 218
UA - Ucraina 158
KR - Corea 138
AR - Argentina 134
IE - Irlanda 132
MX - Messico 108
ZA - Sudafrica 91
CI - Costa d'Avorio 79
SE - Svezia 78
PH - Filippine 77
IQ - Iraq 74
ES - Italia 73
PL - Polonia 66
ID - Indonesia 64
TH - Thailandia 64
AT - Austria 59
IR - Iran 59
EC - Ecuador 47
TR - Turchia 45
CO - Colombia 39
PK - Pakistan 37
TW - Taiwan 37
LT - Lituania 33
BE - Belgio 28
VE - Venezuela 27
MA - Marocco 23
PE - Perù 21
SA - Arabia Saudita 21
EG - Egitto 18
JO - Giordania 18
AE - Emirati Arabi Uniti 17
JM - Giamaica 17
NP - Nepal 17
PY - Paraguay 17
CL - Cile 16
MY - Malesia 16
NI - Nicaragua 15
TN - Tunisia 15
CR - Costa Rica 14
BO - Bolivia 13
DO - Repubblica Dominicana 13
KE - Kenya 13
CZ - Repubblica Ceca 12
HN - Honduras 12
AU - Australia 11
DZ - Algeria 11
IL - Israele 11
UZ - Uzbekistan 11
AM - Armenia 10
BG - Bulgaria 10
DK - Danimarca 9
LB - Libano 9
MK - Macedonia 9
TT - Trinidad e Tobago 9
UY - Uruguay 9
CH - Svizzera 8
GT - Guatemala 8
NG - Nigeria 8
OM - Oman 8
RS - Serbia 8
AZ - Azerbaigian 7
BB - Barbados 7
ET - Etiopia 7
GR - Grecia 7
PT - Portogallo 7
RO - Romania 7
AL - Albania 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
SK - Slovacchia (Repubblica Slovacca) 6
SV - El Salvador 6
MN - Mongolia 5
SN - Senegal 5
CU - Cuba 4
HR - Croazia 4
KH - Cambogia 4
MD - Moldavia 4
MT - Malta 4
PA - Panama 4
QA - Qatar 4
XK - ???statistics.table.value.countryCode.XK??? 4
BH - Bahrain 3
GE - Georgia 3
GF - Guiana Francese 3
Totale 34.508
Salva come PNG Salva come JPEG
Città #
Singapore 2.476
San Jose 2.234
Ashburn 1.064
Hong Kong 951
Moscow 824
Chandler 700
Amsterdam 678
Ho Chi Minh City 616
Beijing 614
Hefei 604
Santa Clara 523
Naples 459
Secaucus 459
Hanoi 456
Council Bluffs 324
Los Angeles 314
Lauterbourg 250
Tokyo 220
The Dalles 217
Millbury 213
New York 189
Dallas 172
Napoli 161
Munich 158
Des Moines 136
Buffalo 131
Princeton 130
Boston 120
Milan 119
São Paulo 119
Nanjing 115
Phoenix 108
Redondo Beach 107
Seoul 107
Da Nang 98
Rome 95
Helsinki 85
Lawrence 84
Frankfurt am Main 83
Seattle 81
Ottawa 80
Haiphong 79
Wilmington 78
Chicago 77
Montreal 75
Toronto 66
Orem 62
Denver 60
London 57
Warsaw 55
Norwalk 53
Houston 51
Brooklyn 49
Mexico City 48
Johannesburg 47
Turku 46
Chennai 45
Falkenstein 45
Jacksonville 45
Stockholm 43
Dublin 41
Atlanta 39
Nuremberg 39
Rio de Janeiro 38
Tianjin 38
Krefeld 33
Poplar 32
Pune 31
Lappeenranta 29
San Francisco 29
Biên Hòa 28
Dong Ket 28
Nanchang 28
Hải Dương 27
Can Tho 26
Belo Horizonte 25
Brasília 25
Vienna 25
Baghdad 24
Charlotte 23
Newark 23
Augusta 22
Bangkok 22
Bari 22
Paris 22
Washington 22
Shenzhen 21
Ankara 19
Curitiba 19
Jiaxing 19
Woodbridge 19
Hebei 18
Manchester 18
Thái Nguyên 18
Fairfield 17
Mumbai 17
Phủ Lý 17
Porto Alegre 17
Quito 17
Amman 16
Totale 18.748
Salva come PNG Salva come JPEG
Nome #
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 1.029
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature 284
Nuove tecniche di imaging nello studio delle alterazioni perfusionali cerebrali e dei processi di degenerazione neuronale in soggetti affetti da sclerosi multipla e da altre patologie neurologiche degenerative. Associazioni tra marcatori radiologici e polimorfismi genetici di predisposizione e decorso delle malattie neurodegenerative 259
Quality of Life and Cognitive function in pediatric and young adults multiple sclerosis: a cross-sectional study 239
Deciphering the role of protein kinase A in the control of FoxP3 expression in regulatory T cells in health and autoimmunity 228
Uric acid: a potential biomarker of multiple sclerosis and of its disability 213
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 206
The ocrelizumab wearing-off phenomenon is associated with reduced immunomodulatory response and increased neuroaxonal damage in multiple sclerosis 198
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 195
MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis 190
Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis 188
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 181
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis 178
Vascular alterations in multiple sclerosis and amyotrophic lateral sclerosis : preliminary analysis of susceptibility factors 175
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy. 173
Affective disorders and Health-Related Quality of Life (HRQoL) in adolescents and young adults with Multiple Sclerosis (MS): the moderating role of resilience 172
The use of medical-grade cannabis in patients non-responders to Nabiximols 171
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression 169
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis 169
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 168
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 168
Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study 167
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod 163
SPG5 and multiple sclerosis: clinical and genetic overlap? 163
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 163
A new POLG1 mutation with peo and severe axonal and demyelinating sensory-motor neuropathy. 162
La sclerosi multipla in età pediatrica ed adolescenziale 162
JCV antibodies index on natalizumab treatment: fluctuations and seroconversion. 160
Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study 159
Being highly sensitive person negatively impacts on cognitive and psychosocial fatigue in multiple sclerosis patients: A cross-sectional, monocenter study 159
Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis 159
Multiple sclerosis and headache co-morbidity. A case-control study 158
Epileptic seizures in multiple sclerosis: clinical and EEG correlations. 158
In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents 157
Quality of life and cognitive functions in early onset multiple sclerosis 156
Normative values of the Rao’s Brief Repeatable Battery in an Italian young adolescent population: the influence of age, gender, and education 155
Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis 154
Imaging of brain perfusion in multiple sclerosis and neurodegenerative disorders: association with endothelial factors. An interim analysis. In MULTIPLE SCLEROSIS JOURNAL (Vol. 20, pp. 297-297). 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND: SAGE PUBLICATIONS LTD. 154
Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020 153
Grey/white matter ratio at diagnosis, and the risk of 10-year multiple sclerosis progression 153
Prevalence and Incidence of Paramagnetic Rim Lesions in Multiple Sclerosis: A Systematic Review and Meta-Analysis 152
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. 152
L'attenzione alle donne nei servizi psicologici offerti dal Centro Regionale Sclerosi Multipla ''Federico II'' di Napoli: l'esperienza del progetto SIM 152
Signs and symptoms of COVID-19 in patients with multiple sclerosis 151
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 151
Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis 151
Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis 150
Tango classes in people with Multiple Sclerosis (PwMS): Impact on motor and non-motor functions 150
Dimethyl Fumarate Mediates Nrf2-dependent Mitochondrial Biogenesis in Mice and Humans 150
Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential 150
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study (Journal of Neurology, (2022), 269, 6, (3301-3307), 10.1007/s00415-022-11009-x) 149
Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin 149
Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy) 149
Cognitive trajectories in multiple sclerosis: a long-term follow-up study 149
Concomitant diagnosis of multiple sclerosis and human immunodeficiency virus (HIV) infection: case report and the review of literature 148
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications 148
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis 148
Modifications of brain tissue volumes in facioscapulohumeral dystrophy. 148
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients 148
MicroRNA-142-3p shuttling in extracellular vesicles marks regulatory T cell dysfunction in multiple sclerosis 147
Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis 147
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. NeuroImage18: 360-366, 2003.. 147
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a 147
Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience 147
Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junction 146
The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease 145
Quality of life and cognitive function in pediatric and young multiple sclerosis patients: a cross-sectional study 145
Determinants of early working impairments in multiple sclerosis 144
Cerebellar lobule atrophy and disability in progressive MS 144
Uric acid in relapsing–remitting multiple sclerosis: a 2-year longitudinal study 143
Biochemical parameters alterations in multiple sclerosis: a longitudinal study and review of the literature. 143
Retinal vascular density in multiple sclerosis: a one year follow up 141
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial 141
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 140
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 140
Lack of correlation between extracranial venous abnormalities and multiple sclerosis: a quantitative MRI study 140
Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study 140
Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015-2017 Prevalence 139
Exploring the relation between reserve and fatigue in multiple sclerosis 138
Increased endothelin-1 serum levels in patients with multiple sclerosis 138
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 138
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak 138
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis 138
Analysis of macrodeletions in the dystrophin gene in patients from southern Italy and correlation between genotype and phenotype. The presence/absence of the III hinge region of the dystrophin protein affects the phenotype. 137
Reduced Annexin A1 Expression Associates with Disease Severity and Inflammation in Multiple Sclerosis Patients 137
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 137
A multiple n-glucosylated peptide epitope efficiently detecting antibodies in multiple sclerosis 137
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis 136
Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis 136
Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment 136
Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery 136
Treatment of multiple sclerosis with rituximab: A multicentric Italian–Swiss experience 136
Asymptomatic bradycardia after first fingolimod dose in a pediatric patient with multiple sclerosis - a case report 135
Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study 135
Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice 135
Vitamin D in a population of Southern Italy relapsing remitting and secondary progressive multiple sclerosis patients. 134
Mobitz type I and II atrioventricular blocks during fingolimod therapy 134
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 134
Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b. 133
Dysphagia assessment in patients with multiple sclerosis - an additional piece to disability burden 132
Totale 16.529
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.138 0 0 9 14 24 85 18 52 123 103 236 474
2022/20232.133 226 187 51 103 222 250 166 156 310 315 106 41
2023/20241.532 62 225 227 94 83 177 72 139 26 40 245 142
2024/20258.348 418 436 52 119 277 521 854 562 618 873 2.822 796
2025/202618.055 1.791 1.839 1.711 1.702 2.925 875 1.999 1.148 2.005 1.173 461 426
2026/20271.739 375 779 585 0 0 0 0 0 0 0 0 0
Totale 35.317